glp 1 and family history of thyroid cancer Glucagon-like peptide receptor agonist use risk cancer: Scandinavian cohort study Nation's Largest Thyroid Cancer Center

Remember that successful long-term weight management typically involves ongoing medical support, lifestyle modifications, and patience as you find the approach that works best for your individual needs

We do this for you before your first appointment

Practical Recommendations for Clinicians Given the inconclusive data on bone safety during GLP1 treatment, clinicians should: Assess fracture risk using tools like FRAX before starting therapy Order BMD tests for patients with osteoporosis risk factors Monitor for excessive or rapid weight loss that may compromise bone mass Promote calcium and vitamin D intake, resistance training, and fall prevention strategies Refer to endocrinologists or bone specialists as needed for complex cases Future Research Questions Several questions remain unanswered about how GLP1 medications influence longterm bone integrity: Do individual GLP1 agents differ in their effects on bone remodeling

But in a model adjusting for the greater weight loss achieved with surgery, GLP-1s were associated with a 41 percent lower relative risk of obesity-related cancers

Additionally, should an entity receive a request for information from FDA, become subject to a facility inspection, or have compounded drug-related compliance issues flagged by a state medical or pharmacy board investigator, the entity should ensure knowledgeable FDA counsel is part of its strategic response team to support development of a comprehensive corrective action plan.

They advocate for personalized treatment plans and caution against overmedication, particularly with testosterone therapy